Grande Alicia's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Mar 24, 2023
- Accession no.
- 0001161697-23-000185
- Filed
- Mar 24, 2023
- Trade date
- Mar 22, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $689.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Grande AliciaCIK 0001402652 | Officer (VP, Treasurer and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 22, 2023 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +3,260 | $0.79 | +$2,575.4 | 53,817 | Direct | |
| Mar 22, 2023 | Common stock, par value $0.001 per share | SSaleDisposed | −3,260 | $16.41 | −$53,496.6 | 50,557 | Direct | |
| Mar 22, 2023 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +38,524 | $0.79 | +$30,433.96 | 89,081 | Direct | |
| Mar 22, 2023 | Common stock, par value $0.001 per share | SSaleDisposed | −38,524 | $16.51 | −$636,031.24 | 50,557 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 22, 2023 | Common Stock | MOption exerciseDisposed | −3,260 | $0.00 | $0 | 1,442,574 | Direct | |
| Mar 22, 2023 | Common Stock | MOption exerciseDisposed | −38,524 | $0.00 | $0 | 1,404,050 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.